Drugs acting on calcium channels modulate the diuretic and micturition effects of dexmedetomidine in rats

Gyöngyi Horváth, Zita Morvay, Mónika Kovács, Annamária Szilágyi, Margit Szikszay

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The purpose of this study was to assess the effects of calcium channel antagonist, verapamil, and agonist, Bay K 8644, on the α2-adrenoceptor agonist, dexmedetomidine-induced (300 μg kg-1 subcutaneously) diuresis and overflow incontinence, in rats. Ultrasonography study revealed that verapamil (2.5 mg kg-1 subcutaneously) or Bay K 8644 (0.5 mg kg-1 intraperitoneally) coadministrations delayed dexmedetomidine-induced bladder filling and significantly prolonged the latency of urination (P<0.05). Bay K 8644 decreased relative bladder volume and stopped continuous urination from dexmedetomidine, whereas verapamil had neither effect. However, none of the drugs eliminated the overflow incontinence. Dexmedetomidine alone increased the hourly and total (for 4 hours) urine volume. Bay K 8644 (0.5 or 1 mg kg-1) dose-dependently decreased the diuretic effect of dexmedetomidine (P<0.001). Verapamil (0.5, 1 or 2.5 mg kg-1) dose-dependently decreased urine volume in the first hour (P<0.01), and thereafter potentiated the diuretic effect of dexmedetomidine. Simultaneous determinations of mean arterial blood pressure (MAP) and urine output after dexmedetomidine and the highest dose of verapamil coadministration demonstrated a significant correlation between these variables (r=0.537; P<0.001). MAP of 100 mmHg or less was associated with a urine output significantly lower (P<0.001) than that at higher pressures. Thus, hypotension during the first hour after dexmedetomidine-verapamil may explain the transient reduction in urination during this period. We conclude that modulation of calcium channels affects dexmedetomidine actions on both urine formation and micturition. Since both α2-adrenoceptor agonists and calcium channel blockers have frequently been used for antihypertensive therapy and as adjuvant drugs during anesthesia, these interactions may have some practical importance.

Original languageEnglish
Pages (from-to)1247-1257
Number of pages11
JournalLife Sciences
Volume59
Issue number15
DOIs
Publication statusPublished - Sep 6 1996

    Fingerprint

Keywords

  • Bay K 8644
  • alpha adrenoceptor agonist
  • calcium channel agonist
  • dexmedetomidine
  • micturition
  • urinary bladder
  • verapamil

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this